Week 1 part 2Chapter 23: Management of Patients with Coronary Vascular Disorders Flashcards

1
Q

Coronary Atherosclerosis

A

Atherosclerosis is the abnormal accumulation of lipid
deposits and fibrous tissue within arterial walls and
lumen
In coronary atherosclerosis, blockages and
narrowing of the coronary vessels reduce blood flow
to the myocardium
Cardiovascular disease is the leading cause of death
in the United States for men and women of all racial
and ethnic groups
Coronary artery disease (CAD) is the most prevalent
cardiovascular disease in adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical Manifestations of Atherosclerosis

A

Symptoms are caused by myocardial ischemia
Symptoms and complications are related to the
location and degree of vessel obstruction
Angina pectoris (most common manifestation)
Other symptoms: epigastric distress, pain that
radiates to jaw or left arm, SOB, atypical symptoms
in women
Myocardial infarction
Heart failure
Sudden cardiac death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk Factors for Coronary Artery Disease
(CAD)

A

Refer to Chart 23-1
o Four modifiable risk factors cited as major
(cholesterol abnormalities, tobacco use, HTN,
and diabetes)
Elevated LDL: primary target for cholesterol-
lowering medication
Framingham risk calculator
Metabolic syndrome
hs-CRP (high-sensitivity C-reactive protein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Prevention of CAD

A

Control cholesterol
Dietary measures
Physical activity
Medications
Cessation of tobacco use
Manage HTN
Control diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cholesterol Medications

A

Six types of lipid-lowering agents: affect the lipid
components somewhat differently (Table 23-1)
o 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-
CoA) (or statins)
o Nicotinic acids
o Fibric acids (or fibrates)
o Bile acid sequestrants (or resins)
o Cholesterol absorption inhibitors
o Omega-3 acid-ethyl esters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Angina Pectoris

A

A syndrome characterized by episodes or
paroxysmal pain or pressure in the anterior chest
caused by insufficient coronary blood flow
Physical exertion or emotional stress increases
myocardial oxygen demand, and the coronary
vessels are unable to supply sufficient blood flow to
meet the oxygen demand
Types of angina
o Refer to Chart 23-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Assessment and Findings for Angina

A

Assessment and Findings for Angina
May be described as tightness, choking, or a heavy
sensation
Frequently retrosternal and may radiate to neck,
jaw, shoulders, back or arms (usually left)
Anxiety frequently accompanies the pain
Other symptoms may occur: dyspnea or shortness
of breath, dizziness, nausea, and vomiting
The pain of typical angina subsides with rest or NTG
Unstable angina is characterized by increased
frequency and severity and is not relieved by rest
and NTG. Requires medical intervention!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gerontologic Considerations for Angina

A

Diminished pain transition that occurs with aging
may affect presentation of symptoms
“Silent” CAD
Teach older adults to recognize their “chest pain–
like” symptoms (i.e., weakness)
Pharmacologic stress testing; cardiac catheterization
Medications should be used cautiously!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment of Angina Pectoris

A

Treatment seeks to decrease myocardial oxygen
demand and increase oxygen supply
Medications
Oxygen
Reduce and control risk factors
Reperfusion therapy may also be done

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Medications for Angina

A

Nitroglycerin
Beta-adrenergic blocking agents
Calcium channel blocking agents
Antiplatelet and anticoagulant medications
Aspirin
Clopidogrel and ticlopidine
Heparin
Glycoprotein IIb/IIIa agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acute Coronary Syndrome (ACS) and
Myocardial Infarction (MI)

A

Emergent situation
Characterized by an acute onset of myocardial
ischemia that results in myocardial death (i.e., MI) if
definitive interventions do not occur promptly
Although the terms coronary occlusion, heart attack,
and MI are used synonymously, the preferred term
is MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Assessment of the Patient with Angina
Pectoris

A

Symptoms and activities, especially those that
precede and precipitate attacks (Chart 23-4)
Risk factors, lifestyle, and health promotion
activities
Patient and family knowledge
Adherence to the plan of care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Collaborative Problems of the Patient with
Angina Pectoris

A

ACS, MI, or both
Arrhythmias and cardiac arrest (see Chapters 22
and 25)
Heart failure (see Chapter 25)
Cardiogenic shock (see Chapter 11)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Planning and Goals for the Patient with
Angina Pectoris

A

Goals
o Immediate and appropriate treatment of angina
o Prevention of angina
o Reduction of anxiety
o Awareness of the disease process
o Understanding of prescribed care and adherence
to the self-care program
o Absence of complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nursing Interventions for the Patient with
Angina Pectoris

A

Treat angina
Reduce anxiety
Prevent pain
Educate patients about self-care
Continuing care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nursing Intervention: Treat Angina

A

Priority
Patient is to stop all activities and sit or rest in bed
(semi-Fowler positioning)
Assess the patient while performing other necessary
interventions. Assessment includes VS, observation
for respiratory distress, and assessment of pain. In
the hospital setting, the ECG is assessed or obtained
Administer medications as ordered or by protocol,
usually NTG. Reassess pain and administer NTG up
to three doses
Administer oxygen 2 L/min by nasal cannula

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Nursing Intervention: Reduce Anxiety

A

Use a calm manner
Stress-reduction techniques
Patient teaching
Addressing patient’s spiritual needs may assist in
allaying anxieties
Address both patient and family needs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nursing Intervention: Preventing Pain

A

Identify level of activity that causes patient’s
prodromal S&S
Plan activities accordingly
Alternate activities with rest periods
Educate patient and family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nursing Intervention: Patient Teaching #1

A

Balance activity with rest
Follow prescribed exercise regimen
Avoid exercising in extreme temperatures
Use resources for emotional support (counselor)
Avoid over-the-counter medications that may
increase HR or BP before consulting with health care
provider
Stop using tobacco products (nicotine increases HR
and BP)
Diet low in fat and high in fiber

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Nursing Intervention: Patient Teaching #2

A

Medication teaching (carry NTG at all times!)
Follow up with health care provider
Report increase in S&S to provider
Maintain normal BP and blood glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Assessment of the Patient with ACS

A

Chest pain
o Occurs suddenly and continues despite rest and
medication
o Other S&S: SOB; C/O indigestion; nausea;
anxiety; cool, pale skin; increased HR, RR
ECG changes
o Elevation in the ST segment in two contiguous
leads is a key diagnostic indicator for MI
Lab studies: cardiac enzymes, troponin, creatine
kinase, myoglobin

22
Q

Collaborative Problems of the Patient with
ACS

A

Acute pulmonary edema (see Chapter 25)
Heart failure (see Chapter 25)
Cardiogenic shock (see Chapter 11)
Arrhythmias and cardiac arrest (see Chapters 22
and 25)
Pericardial effusion and cardiac tamponade (see
Chapter 25)

23
Q

Planning and Goals for the Patient with
ACS

A

Goals:
o Relief of pain or ischemic signs (e.g., ST-
segment changes) and symptoms
o Prevention of myocardial damage
o Maintenance of effective respiratory function,
adequate tissue perfusion
o Reduction of anxiety
o Adherence to the self-care program
o Early recognition of complications

24
Q

Nursing Interventions for the Patient with
ACS

A

Relieve pain and S&S of ischemia
Improve respiratory function
Promote adequate tissue perfusion
Reduce anxiety
Monitor and manage potential complications
Educate patient and family
Provide continuing care

25
Q

Nursing Management of the Patient with
ACS

A

Oxygen and medication therapy
Frequent VS assessment
Physical rest in bed with head of bed elevated
Relief of pain helps decrease workload of heart
Monitor I&O and tissue perfusion
Frequent position changes to prevent respiratory
complications
Report changes in patient’s condition
Evaluate interventions!

26
Q

Invasive Coronary Artery Procedures

A

Percutaneous transluminal coronary angioplasty
(PTCA)
Coronary artery stent
Coronary artery bypass graft (CABG)
Cardiac surgery

27
Q

Nursing Management: Patient Requiring
Invasive Cardiac Intervention #1

A

Assessment of patient
Reduce fear and anxiety
Monitor and manage potential complications
Provide patient education
Maintain cardiac output
Promote adequate gas exchange
Maintain fluid and electrolyte balance
Minimize sensory–perception imbalance

28
Q

Nursing Management: Patient Requiring
Invasive Cardiac Intervention #2

A

Relieve pain
Maintain adequate tissue perfusion
Maintain body temperature
Promote health and community-based care

29
Q

Cardiac-Specific Troponin:

A

Cardiac-Specific Troponin:
►Troponin T (cTnt): <0.1 ng/mL (>2.3 + cardiac injury)
►Troponin I (cTnI): <0.5 ng/mL
►Creatine Kinase MB (CK-MB): < 4%-6% total CK
►Myoglobin: 11.1 mcg/L – 91.2 mcg/L

30
Q

Which result is the most important?

A

►Troponin T (cTnt)
►Why?

31
Q

How do you differentiate between Unstable
Angina (UA) and Non-Stemi (NSTEMI)?

A

►ECG
►Serum Cardiac Biomarkers

32
Q

What are your priority nursing interventions?

A

► Medications: Continue O2, Administer Nitroglycerin
and Aspirin
► Monitor: Continually assess patient: Airway,
breathing efforts, hemodynamic status, cardiac
arrhythmias
► Prepare for percutaneous coronary intervention (PCI).
► Would you wait for laboratory results prior to sending
patient to the cardiac catheterization lab? Why or
why not?

33
Q

Cardiac Catheterization Lab:

A

Cardiac Catheterization Lab:
► Arterial Access: Radial or Femoral
► Percutaneous Coronary Intervention (PCI): An
endovascular procedure that is minimally invasive
where a small incision is made into a vessel using a
needle puncture, guidewire and sheath to provide
access to diagnose/treat.
► Percutaneous Transluminal Coronary Angioplasty
(PTCA): Locate and assess blockage and determine
extent of collateral circulation along with left
ventricular function.
► Balloon Angioplasty: Widening of blocked or narrowed
vessel by balloon catheter.
► Stent Placement: Bare Metal or Drug-Eluting

34
Q

What medications are used
during a cardiac catheterization?

A

►Midazolam
►For Sedation
►Fentanyl
►For Pain Control

35
Q

What are the benefits
of PCI over
Coronary Artery Bypass Graft (CABG)?

A

►Minimally Invasive
►Low Risk
►Quick Recovery

36
Q

What is the goal of PCI?

A

►Quickly open up blocked
arteries to allow oxygen-rich
blood to circulate to the entire
heart muscle with minimal risk
and recovery.

37
Q

What are your expectations s/p
reperfusion? -aka- What will you
frequently assess?

A

►No Chest Pain
►Normal ECG
►Normal Vital Signs
►Normal Neuro Status
►Normal Heart and Lung Sounds
►No Bleeding (External or Internal)

38
Q

How often will you draw serum cardiac
biomarkers post PCI?

A

► Q 6 hours x 3
► What will happen to serum cardiac biomarkers s/p
reperfusion therapy?
► Early and rapid rise within three hours of reperfusion
therapy.
► Peaking within 12 hours.
► Why do these levels increase?
►Necrotic heart cells release proteins into circulation
after perfusion is restored to the area.

39
Q

What are some PCI complications that can
lead to an emergent Coronary Artery Bypass
Graft (CABG).

A

► Dissection
► Rupture
► Acute Stent Thrombosis
► Restenosis (Reocclusion)
► Coronary Spasm
► Bleeding
► Stroke
► Infection

40
Q

When would a patient receive a thrombolytic?

A

►No Cardiac Catheter Lab
►Thrombolytic Requirements:
►Chest Pain < 12 hours
►STEMI only
►No contraindications

41
Q

What is the goal of Thrombolytic Therapy?

A

►Limit Infarction Size
►Get Patient to Cardiac Cath Lab ASAP
►Thrombolytic Therapy Risks?
►Bleeding
►Reocclusion of Artery

42
Q

Absolute Contraindications:

A

► Intracranial Hemorrhage History
► Known Abnormalities
► Recent Stroke
► Recent Trauma
► Intracranial Cancer
► Severe Uncontrolled Hypertension
► Active Internal Bleeding
► Suspected Aortic Dissection
► Prior Treatment (Streptokinase)
► Recent Intracranial/Spinal Surgery

43
Q

ACS Medications: Why do we give them?

A

►Dual Antiplatelet Therapy
►Nitroglycerin
►Morphine
►Beta Blocker
►Lipid-Lowering Drugs
►ACE/ARB
►Antidysrhythmics
►Stool Softeners

44
Q

Dual Antiplatelet Therapy:

A

Antiplatelets stop platelets from clumping
together and forming blood clots. Dual antiplatelet therapy (DAPT) is
defined as the use of a P2Y12 receptor inhibitor (clopidogrel,
ticagrelor, and prasugrel) and aspirin. (Clopidogrel, Aspirin)

45
Q

► Nitroglycerin:

A

A nitrate resulting in vasodilation to relieve angina
occurring when the heart muscle is deprived of blood/oxygen.

46
Q

► Morphine:

A

A potent opioid providing analgesia along with vasodilation
and decreasing cardiac workload (decreases heart rate, blood
pressure and venous return). As a result, myocardial oxygen demand
is decreased.

47
Q

► Beta Blocker:

A

Used to manage abnormal heart rhythms and for
patients with acute MI, beta blocker therapy reduces infarct size and
early mortality when started early and lowers the risk of death when
continued long term. (Atenolol, Metoprolol)

48
Q

► Lipid-Lowering Drugs:

A

Decrease the levels of fats in the blood.
Lowering cholesterol levels that are too high lessens the risk for
developing heart disease and reduces the chance of a heart attack or
dying of heart disease, even if the patient already has it.ACE/ARB
(Atorvastatin, Simvastatin)

49
Q

► Antidysrhythmics:

A

Used to reduce mortality in post MI patients with
ventricular ectopic activity which has an adverse effect on prognosis
post MI. (Amiodarone)

50
Q

► Stool Softener:

A

Used to prevent straining during a bowel movement
which should be avoided after an MI or surgery. Straining can trigger
a vasovagal response where the vagus nerve sends a message to the
brain causing a sudden drop in blood pressure and heart rate which
can trigger a cardiovascular event, such as arrhythmia. (Docusate)